Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Network Neurometrics is a medical technology company specializing in advanced electroencephalogram (EEG) analysis and quantitative EEG (qEEG) software. The company develops sophisticated tools for brain mapping, connectivity analysis, and neurofeedback, primarily used for diagnosing and monitoring neurological conditions such as traumatic brain injury, ADHD, and learning disabilities. Their core technology, integrated into the NeuroGuide software suite, utilizes extensive normative databases to compare individual brain function against healthy controls. By providing high-resolution spatial and temporal imaging of brain activity, the company supports clinicians in developing targeted neurotherapy protocols. Network Neurometrics remains a leader in the field of clinical neuroscience through its focus on Z-score neurofeedback and brain network analysis.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Network Neurometrics.